Sunitinib Newbury 50 mg Norge - norsk - Statens legemiddelverk

sunitinib newbury 50 mg

newbury pharmaceuticals ab - sunitinibmalat - kapsel, hard - 50 mg

Sunitinib Newbury 12.5 mg Norge - norsk - Statens legemiddelverk

sunitinib newbury 12.5 mg

newbury pharmaceuticals ab - sunitinibmalat - kapsel, hard - 12.5 mg

Sunitinib Newbury 25 mg Norge - norsk - Statens legemiddelverk

sunitinib newbury 25 mg

newbury pharmaceuticals ab - sunitinibmalat - kapsel, hard - 25 mg

Sunitinib Teva 12.5 mg Norge - norsk - Statens legemiddelverk

sunitinib teva 12.5 mg

teva b.v. - sunitinib - kapsel, hard - 12.5 mg

Sunitinib Teva 25 mg Norge - norsk - Statens legemiddelverk

sunitinib teva 25 mg

teva b.v. - sunitinib - kapsel, hard - 25 mg

Sunitinib Teva 50 mg Norge - norsk - Statens legemiddelverk

sunitinib teva 50 mg

teva b.v. - sunitinib - kapsel, hard - 50 mg

Orserdu Den europeiske union - norsk - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - bryst neoplasms - endokrin terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Erwinase 10000 E Norge - norsk - Statens legemiddelverk

erwinase 10000 e

porton biopharma limited - krisantaspase - pulver til injeksjons-/infusjonsvæske, oppløsning - 10000 e

Bosulif 400 mg Norge - norsk - Statens legemiddelverk

bosulif 400 mg

abacus medicine a/s - bosutinibmonohydrat - tablett, filmdrasjert - 400 mg

Bosulif 100 mg Norge - norsk - Statens legemiddelverk

bosulif 100 mg

2care4 aps - bosutinibmonohydrat - tablett, filmdrasjert - 100 mg